Table 2.
Follow-up schedule
| V0 | Cath | PCI | CABG | PTA | V1 | V2 | V3 | V4 | V5 | V6 | V7 | V8 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Time elapse from PTA | 0 | 30 (±7)D | 24 (±2)W | 48 (±2)W | 72 (±2)W | 96 (±2)W | 120 (±2)W | 144 (±2)W | 168 (±2)W | ||||
| CRF | 001 | 002 | 003 | 004 | 005 | 006 | 007 | 008 | 009 | 010 | 011 | 012 | 013 |
| Markers/SNPs/miRNAs | X | ||||||||||||
| CBC | X | ||||||||||||
| BCS | X | ||||||||||||
| BW/BH | X | ||||||||||||
| BP/HR | X | X | X | X | X | X | X | X | X | ||||
| History and PE | X | X | X | X | X | X | X | X | X |
BCS biochemistry study, BH body height, BP blood pressure, BW body weight, CABG coronary artery bypass grafting, Cath coronary catheterization, CBC complete blood cell count, CRF case report form, D days, HR heart rate, miRNAs micro-ribonucleic acids, PCI percutaneous coronary intervention, PE physical examination, PTA percutaneous transluminal angioplasty, SNPs single-nucleotide polymorphisms, V visit, W weeks